Lectin drug conjugate therapy for colorectal cancer

Drug resistance represents an obstacle in colorectal cancer (CRC) treatment because of its association with poor prognosis. rBC2LCN is a lectin isolated from Burkholderia that binds cell surface glycans that have fucose moieties. Because fucosylation is enhanced in many types of cancers, this lectin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitaguchi, Daichi, Oda, Tatsuya, Enomoto, Tsuyoshi, Ohara, Yusuke, Owada, Yohei, Akashi, Yoshimasa, Furuta, Tomoaki, Yu, Yang, Kimura, Sota, Kuroda, Yukihito, Kurimori, Ko, Miyazaki, Yoshihiro, Furuya, Kinji, Shimomura, Osamu, Tateno, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734164/
https://www.ncbi.nlm.nih.gov/pubmed/33058342
http://dx.doi.org/10.1111/cas.14687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734164/
https://www.ncbi.nlm.nih.gov/pubmed/33058342
http://dx.doi.org/10.1111/cas.14687

Ejemplares similares